- Opus Holdings (OTC: CATV) to change ticker to OPHD, introducing significant leadership shifts.
- Achieved $500K in Q4 revenue, eliminated $830K in debt, and reduced over 8 billion dilutive shares.
- Aiming for 3-5 spin-offs across biotech, wellness, tech, and consumer goods within 24 months.
Opus Holdings (OTC: CATV), soon to be OTC: OPHD, has announced strategic leadership appointments aimed at transforming the company into a top-tier business incubator. CEO Susan Ward leads the initiative, with Israel Mirsky joining as Senior Advisor and Natacha St. Louis as Business Development head. Together, they bring over 65 years of combined experience essential for driving the company's aggressive growth strategy.
The company reported significant financial achievements, including generating $500K in Q4 revenue, eliminating $830K in debt, and reducing over 8 billion dilutive shares. Q1 2025 sales have remained stable, supporting their robust business incubation strategy.
Under the new leadership, Opus Holdings plans to execute 3-5 spin-offs within the next 24 months, focusing on the biotech, wellness, tech, and consumer goods sectors. This initiative aims to accelerate company acquisitions and transition them through IPOs or public mergers, positioning the incubator to maximize shareholder value.
Israel Mirsky brings experience from OMD Worldwide and Intel, emphasizing digital acceleration and sustainable innovation. Natacha St. Louis adds 20 years of expertise in economic development and compliance, vital for scaling Opus's portfolio companies. Their leadership will help in acquiring, developing, and transitioning private companies into public markets.
